EUVIMEDEUVIMED entdecken
Open Access

Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism

Emily C Kappes iD, Chandramohan Kattamuri iD, Magdalena Czepnik iD, Alexander E Yarawsky iD, Emilie Brûlé iD, Ying Wang, Luisina Ongaro iD, Andrew B Herr iD, Kelly L Walton iD, Daniel J Bernard iD, Thomas B Thompson iD

Endocrinology · 2023

DOI: 10.1210/endocr/bqad017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2023. Verfasst von Emily C Kappes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, USA. Hauptthemen laut MEDLINE: Follistatin, Glycoproteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibins are transforming growth factor-β family heterodimers that suppress follicle-stimulating hormone (FSH) secretion by antagonizing activin class ligands. Inhibins share a common β chain with activin ligands. Follistatin is another activin antagonist, known to bind the common β chain of both activins and inhibins. In this study, we characterized the antagonist-antagonist complex of inhibin A and follistatin to determine if their interaction impacted activin A antagonism. We isolated the inhibin A:follistatin 288 complex, showing that it forms in a 1:1 stoichiometric ratio, different from previously reported homodimeric ligand:follistatin complexes, which bind in a 1:2 ratio. Small angle X-ray scattering coupled with modeling provided a low-resolution structure of inhibin A in complex with follistatin 288. Inhibin binds follistatin via the shared activin β chain, leaving the α chain free and flexible. The inhibin A:follistatin 288 complex was also shown to bind heparin with lower affinity than follistatin 288 alone or in complex with activin A. Characterizing the inhibin A:follistatin 288 complex in an activin-responsive luciferase assay and by surface plasmon resonance indicated that the inhibitor complex readily dissociated upon binding type II receptor activin receptor type IIb, allowing both antagonists to inhibit activin signaling. Additionally, injection of the complex in ovariectomized female mice did not alter inhibin A suppression of FSH. Taken together, this study shows that while follistatin binds to inhibin A with a substochiometric ratio relative to the activin homodimer, the complex can dissociate readily, allowing both proteins to effectively antagonize activin signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FollistatinGlycoproteinsFemaleMiceAnimalsInhibinsActivinsLigandsFollicle Stimulating Hormone

Stichwörter der Autor:innen

activin antagonismantagonist complexfollistatinheterodimerinhibin

Substanzen

inhibin Aactivin AFollistatinGlycoproteinsInhibinsActivinsLigandsFollicle Stimulating Hormone

Autor:innen und Institutionen

  • Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, USA.
  • Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Departments of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada.
  • Departments of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada.
  • School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

ORCID-Profile: Emily C Kappes, Chandramohan Kattamuri, Magdalena Czepnik, Alexander E Yarawsky, Emilie Brûlé, Luisina Ongaro, Andrew B Herr, Kelly L Walton, Daniel J Bernard, Thomas B Thompson

Förderung

  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Canadian Institutes of Health Research
  • National Health and Medical Research Council Australia

Zitieren

APA

Kappes, E. C., Kattamuri, C., Czepnik, M., Yarawsky, A. E., Brûlé, E., Wang, Y., Ongaro, L., Herr, A. B., Walton, K. L., Bernard, D. J., & Thompson, T. B. (2023). Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism. Endocrinology. https://doi.org/10.1210/endocr/bqad017

Vancouver

Kappes EC, Kattamuri C, Czepnik M, Yarawsky AE, Brûlé E, Wang Y, et al. Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism. Endocrinology. 2023. doi:10.1210/endocr/bqad017

BibTeX
@article{Kappes2023,
  author = {Kappes, Emily C and Kattamuri, Chandramohan and Czepnik, Magdalena and Yarawsky, Alexander E and Brûlé, Emilie and Wang, Ying and Ongaro, Luisina and Herr, Andrew B and Walton, Kelly L and Bernard, Daniel J and Thompson, Thomas B},
  title = {Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism},
  journal = {Endocrinology},
  year = {2023},
  doi = {10.1210/endocr/bqad017}
}
Kostenlos starten →